Quick Overview
- Shares of Palantir climbed 2.3% in pre-market trading to $131.05 on Monday, April 13.
- Donald Trump endorsed the defense technology firm on Truth Social, highlighting its military applications.
- ARK Invest, led by Cathie Wood, acquired 85,485 shares of PLTR valued between $10.95 million and $11.15 million across five exchange-traded funds.
- The flagship ARKK ETF accounted for the largest portion with 46,455 shares, while ARKQ, ARKW, ARKF, and ARKX also participated.
- Year-to-date, PLTR remains down 28% in 2026 while trading at a premium valuation of 99 times projected 2026 earnings.
Shares of Palantir received a boost Monday morning thanks to two significant catalysts: an endorsement from the president and a substantial investment from one of Wall Street’s most prominent fund managers.
The data analytics company’s shares advanced 2.3% during pre-market hours, reaching $131.05 before regular trading commenced. This upward movement occurred despite broader market weakness — S&P 500 futures declined 0.6% amid investor concerns following Trump’s directive for the U.S. Navy to establish a blockade in the Strait of Hormuz.
Palantir Technologies Inc., PLTR
Trump took to Truth Social on Friday with a message of support: “Palantir Technologies (PLTR) has proven to have great war fighting capabilities and equipment. Just ask our enemies!!!” This endorsement provided momentum for PLTR, helping the stock recover some ground during a trading session already marked by market anxiety surrounding Anthropic’s newest AI model release.
This isn’t the initial instance of Trump’s commentary influencing the company’s share price, and market observers expect similar dynamics to continue.
Cathie Wood’s Firm Accumulates Palantir Shares
According to ARK Invest’s daily trading disclosure for April 11, the investment firm acquired 85,485 Palantir shares distributed across five of its actively managed ETFs. The aggregate transaction value ranged from approximately $10.95 million to $11.15 million based on execution pricing.
The ARKK Innovation ETF led the buying activity with 46,455 shares. The Autonomous Technology & Robotics ETF (ARKQ) added 15,127 shares, the Next Generation Internet ETF (ARKW) purchased 11,865 shares, the Fintech Innovation ETF (ARKF) acquired 5,973 shares, and the Space Exploration & Innovation ETF (ARKX) bought 6,065 shares.
Wood has maintained a bullish stance on Palantir for an extended period. Given the stock’s significant decline from recent peaks, this transaction appears to represent ARK’s strategy of increasing exposure to high-conviction holdings during price corrections.
Balancing these purchases, ARK divested 44,446 shares of Advanced Micro Devices valued at approximately $10.52 million across the same ETF portfolio. The firm also liquidated 75,389 shares of Strata Critical Medical (SRTA) for roughly $305,000, extending a pattern of reducing that holding.
Valuation Concerns Persist
Despite Monday’s encouraging developments, Palantir continues facing substantial headwinds in 2026. The stock has experienced a 28% decline year-to-date, representing a significant reversal from the elevated levels achieved in late 2025.
The central debate among market participants centers on valuation metrics. Trading at 99 times anticipated 2026 earnings, the market is embedding substantial growth expectations into the current share price. Critics question whether Palantir can achieve revenue and profit expansion at a pace sufficient to justify this premium — particularly as artificial intelligence technologies transform the enterprise software sector where the company competes.
This dynamic between robust demand from government and defense contractors and an elevated valuation multiple has characterized the investment narrative throughout this year.
Monday’s pre-market trading positioned PLTR near $131.05. ARK’s share accumulation occurred at Friday’s closing price, which settled around $128.





